Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors.

Fiche publication

Date publication

octobre 2022

Journal

Endocrine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CADIOT Guillaume

Tous les auteurs :
Lelièvre M, Triumbari EKA, Brixi H, Perrier M, Cadiot G, Deguelte S, Morland D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36203032

Résumé

Bone metastases (BM) affect 10-30% of patients with small intestine neuroendocrine tumors (siNET), but little descriptive data are available regarding their distribution throughout the skeleton or potential risk factors. Aim of the study is to better describe the imaging characteristics, distribution, and risk factors of siNET bone metastases using 18F-FDOPA PET/CT.